<DOC>
	<DOCNO>NCT00856635</DOCNO>
	<brief_summary>The main objective study determine whether glatiramer acetate 20 mg daily reduces amount axonal loss optic nerve first event acute optic neuritis compare placebo patient generate data support potential neuroprotective effect glatiramer acetate human vivo model axonal loss .</brief_summary>
	<brief_title>A Randomized , Double-blind , Placebo-controlled , Multicenter Study Effects Glatiramer Acetate ( GA ) Retinal Nerve Fiber Layer ( RNFL ) Visual Function Patients With First Episode Acute Optic Neuritis ( AON ) . ( Octagon )</brief_title>
	<detailed_description />
	<mesh_term>Optic Neuritis</mesh_term>
	<mesh_term>Neuritis</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>Age : 18 45 year Isolated , unilateral , first acute optic neuritis ( AON ) event consistent inflammatory demyelinization , explain etiology . Onset AON define presentation visual disturbance . Able provide write informed consent prior enrollment Willing able comply protocol requirement duration study For woman child bear potential : A negative urine pregnancy test Willing practice acceptable method birth control â€¢ Willing receive steroidal regimen A diagnosis clinically definite multiple sclerosis ( MS ) ( Clinically Definite Multiple Sclerosis ) Current use approve disease modify agent treatment MS Prior clinical episode optic neuritis either eye Bilateral AON Inability undergo study evaluation eye Known ocular neurological condition abnormality refractive error impair visual function Retrogeniculate visual loss Refractive error great +6 6 diopter Neuromyelitis Optica ( Devic 's disease ) Systemic diseases cause inflammatory optic neuropathy , include limited Sarcoidosis , Systemic lupus erythematosus ( SLE ) , Wegener 's Granulomatosis , Syphilis , human immunodeficiency virus ( HIV ) Known ocular condition preclude dilation Any condition may interfere performance Optical Coherence Tomography ( OCT ) : corneal , lens fundoscopic abnormality , comorbid ocular condition relate optic neuritis detect OCT read Any condition precludes administration Glatiramer Acetate , know history sensitivity mannitol Diabetes Mellitus Types I II Gastric bypass surgery Current use chemotherapy radiotherapy Treatments may cause visual loss plaquenil , antitubercular agent , interferon ( IFN ) alpha therapy , monoclonal antibody Cardiac medication may affect visual evaluation digitalis , amiodarone , quinine Ongoing treatment steroid ( longer 10 day ) within last 3 month Significant unstable medical , systemic , psychiatric logistical condition affect patient 's ability give inform consent complete study procedure Use investigational drug within 30 day prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>